267 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
be guaranteed and there is no assurance that the company will achieve its financial guidance and long-term targets, that the company’s future clinical
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Based Targets (SBT) Published first Task Force on Climate Related Financial Disclosure (TCFD) Report Executed a second 15-year virtual power purchase
8-K
EX-99.1
9v0odkq3bybmn9w5ws
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
rjqvfndlz
8 Jan 24
Regulation FD Disclosure
10:29am
SC TO-C
EX-99.2
990904qqzre7
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
s2a97yicrhdlktow
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
EX-99.1
k8jk0ijibiuv
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
2zozy919bl
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.2
rgx v70mfq4
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
c1hjn6obz
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
rjkub 9vm
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.1
vwdvv006rzm3l wbdl
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.2
sat96 7flfyg
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am